William M. McClements, SVP of Corporate Operations at MERRIMACK PHARMACEUTICALS INC (MACK), bought 7,000 shares at $3.56 ($25K) on 2013-11-27, disclosed to the SEC on 2013-12-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.56 | 6,000 | $21K | 84.5% |
| 2 | $3.91 | 1,000 | $4K | 15.5% |
| Total | $3.61 avg | 7,000 | $25K | 100% |
| Filing → |
| MACK | BUY | 2013-12-04 | $8K | — | Filing → |